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Objective. To assess quality of care of women with severe maternal morbidity and to identify associated factors. Method. This
is a national multicenter cross-sectional study performing surveillance for severe maternal morbidity, using the World Health
Organization criteria. The expected number of maternal deaths was calculated with the maternal severity index (MSI) based on
the severity of complication, and the standardized mortality ratio (SMR) for each center was estimated. Analyses on the adequacy
of care were performed. Results. 17 hospitals were classified as providing adequate and 10 as nonadequate care. Besides almost
twofold increase in maternal mortality ratio, the main factors associated with nonadequate performance were geographic difficulty
in accessing health services (𝑃 < 0.001), delays related to quality of medical care (𝑃 = 0.012), absence of blood derivatives
(𝑃 = 0.013), difficulties of communication between health services (𝑃 = 0.004), and any delay during thewhole process (𝑃 = 0.039).
Conclusions. This is an example of how evaluation of the performance of health services is possible, using a benchmarking tool
specific to Obstetrics. In this study the MSI was a useful tool for identifying differences in maternal mortality ratios and factors
associated with nonadequate performance of care.
1. Introduction
The outcome of a critically ill patient is a result of clinical
and individual factors, including previous health status,
physiologic reserve, disease diagnosis, and also adequacy
of care provided during the disease. Thus, it is difficult
to individually analyze and predict morbidity and mortal-
ity outcomes in critically ill patients [1]. Stratification of
patient groups according to clinical severity may facilitate
interpretation of these results by comparing similar groups
[2].
Some scoring systems are capable of quantifying severity,
for example, the APACHE (Acute Physiology and Chronic
Health Evaluation), SAPS (Simplified Acute Physiology
Score), SOFA (Sequential Organ Failure Assessment), and
MPM (Mortality Prediction Model) [1]. However, they were
developed using general populations of critically ill patients
in high income countries. Considering severe pregnancy
complications, several factors seem to reduce the capacity
to classify severity and predict mortality among pregnant
women with these models.
The different physiologic parameters, diseases unique to
pregnancy, and a population largely composed of young
women who were previously healthy contribute to the little
applicability of these tools in Obstetrics [3]. As a result,
traditional risk stratification models usually overestimate
mortality among pregnant women, which may hinder anal-
ysis of the performance of care provided and interpretation
of morbidity and mortality outcomes [3].
“Benchmarking” may be understood as a reference point
against which comparisons can be made, regarding the
performance between facilities and/or best practice. The
demand for this type of data is growing, not only due to
initiatives to pay for performance but also because of clin-
ical, administrative, and research applications. Performance
feedback at an institutional or individual level may lead to an
improvement in overall performance [2].
Several initiatives for maternal and infant health have
been implemented worldwide, aimed at achieving the mil-
lennium development goals (MDG) [4–8]. Nevertheless,
advances made over the years are below those required
for effective morbidity and mortality reduction. Structured
health systems are identified as fundamental to obtain better
results and accelerate progress for achieving these goals [9,
10].
TheWorld Health Organization (WHO) used organ dys-
function criteria and parameters of extreme severity specific
to Obstetrics to define life-threatening conditions associated
with pregnancy, standardizing thematernal nearmiss criteria
[8]. Amaternal nearmiss is an event inwhich awomannearly
died, but survived a severe complication occurring during
pregnancy, childbirth, or within 42 days of its termination. It
represents the extreme degree of organ dysfunction/failure in
the wide spectrum of morbidity and differs from death only
by the final outcome [8].
Until this definition, several studies used different param-
eters for severe morbidity, such as admission to intensive
care units (ICU) or clinical diagnoses [11–14]. The first
retrospective validation of these criteria was performed in a
population of obstetric patients admitted to ICU, using the
totalmaximumSOFA score as the gold standard and showing
that the WHO near miss criteria obtained a sensitivity and
specificity of 99.2 and 86.0%, respectively, for the identifica-
tion of organ failure in at least one organ system [15].
The Brazilian Network for Surveillance of Severe Mater-
nal Morbidity was a prospective study aimed at identifying
potentially life-threatening and maternal near miss cases
[16, 17]. Assuming that a woman suffering from a near
miss event is exactly like one who has died, except for the
outcome, criteria would be validated if all maternal deaths
were identified and if the false-positive cases represented
exactly the near miss cases. The performance of the WHO
near miss criteria was confirmed, with a sensitivity and
specificity of 100 and 92%, respectively [18]. In this study a
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Table 1: TheWHO set of severity markers (life-threatening conditions) used in maternal near miss assessments.
Group A Group B
Cardiovascular dysfunction
Shock pH < 7.1
Lactate > 5 Use of continuous vasoactive drugs
Cardiac arrest
Cardiopulmonary resuscitation (CPR)
Respiratory dysfunction
Acute cyanosis Gasping
Respiratory rate >40 or <6/min PaO2/FiO2 < 200mmHg
Oxygen saturation <90% for ≥60 minutes Intubation and ventilation not related to anesthesia
Renal dysfunction Oliguria nonresponsive to fluids or diuretics Creatinine ≥300mmol/L or ≥3.5mg/dL
Dialysis for acute renal failure
Coagulation/hematological
dysfunction
Clotting failure Acute thrombocytopenia (<50 000 platelets)
Transfusion of ≥5 units of blood/red cells
Hepatic dysfunction Jaundice in the presence of preeclampsia Bilirubin >100mmol/L or >6.0mg/dL
Neurological dysfunction
Metabolic coma (loss of consciousness AND
the presence of glucose and keto acids in urine)
Coma/loss of consciousness lasting 12 hours or
more
Stroke
Status epilepticus/uncontrollable fits/total paralysis
Uterine dysfunction Hysterectomy due to infection or hemorrhage
Source: reference [18].
tool called maternal severity index (MSI) was also developed
specifically to predict mortality for the obstetric population.
This appears to be a first step in making a case-mix analysis
and a comparison between obstetric services by matching
similar populations [18].
Strategies aimed at strengthening health systems are nec-
essary. However, many systems still do not have the capacity
to measure and understand their own weaknesses, making
it difficult for healthcare policy managers to incorporate
scientific strategies towards strengthening systems [10]. The
maternal near miss approach may be a tool for assessment of
quality ofmaternal care provided. As a result, standardization
and comparison can be made between maternal morbidity
groups from different locations and over time, identifying
weaknesses [7]. Thus, the aim of this study was to simulate
the evaluation of an obstetric health system, through analysis
of the performance of care in the Brazilian Network for
the Surveillance of Severe Maternal Morbidity, using the
maternal near miss criteria approach.
2. Materials and Methods
2.1. Ethics Statement. Research protocol was approved by the
Institutional Review Board of the coordinating institution
(University of Campinas) on 5 May 2009 (Document CEP
027/2009). The study was approved by the local Institutional
ReviewBoard of each participating center and also nationally.
Each center was previously consulted regarding this analysis
of performance and data publication. Approval was unani-
mous. To ensure confidentiality, each center is not identified
and received confidential information on the category it was
classified in order to be able to adopt procedures to improve
quality of care provided.
2.2. Study Population. The Brazilian Network for Surveil-
lance of Severe Maternal Morbidity was a cross-sectional
multicenter study aimed at identifying severe maternal mor-
bidity cases, using the new WHO definition [8, 16]. From
July 2009 to June 2010, 27 referral hospitals, representing
a purposeful sample of the Brazilian health facilities caring
for women’s deliveries, made a prospective surveillance to
identify severe maternal morbidity/near miss cases.
The study was planned in detail, with preparatory meet-
ings to discuss methods and procedures with participants
from all centers. In addition to personal and clinical infor-
mation of each case of severe maternal morbidity identi-
fied, a rigorous system of screening for any of the three
delays in obstetrical care was also implemented [19]. After
prospective data collection was completed, a rigorous check-
ing system for data consistency was developed. Additional
details on method and procedures are in other publications
[16, 17].
2.3. Development of a Model for Mortality Prediction. Pre-
viously, it was possible to build a model for mortality
prediction, namedmaternal severity index (MSI) [18]. Briefly,
two models for mortality prediction were developed. First,
it was confirmed that the number of near miss markers
could be related to mortality and this correlation was called
maternal severity score (MSS). The WHO near miss mark-
ers are shown in Table 1, distributed as Group A (organ
dysfunction) and Group B (severe dysfunction/failure). Two
models of bivariate logistic regression were then developed
and tested to describe the relationship between severe mor-
bidity and mortality. For this, the total study population was
divided into two subpopulations “A” and “B” to develop and
test the prediction model, respectively. The sample size of
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Figure 1: SMR calculator.
population “B” was obtained considering a probability of 0.05
for type I error, 0.20 for type II error, and a minimum area
under the ROC (receiver operating characteristic) curve of
0.80.
The first model was a univariate analysis including only
MSS or the number of severity markers. The second used
univariate analyses considering MSS, distal predictors of
mortality (such as demographic and obstetric characteris-
tics), and near miss criteria as independent variables and
the outcome maternal death as the dependent variable.
Variables significantly correlatedwithmortality were selected
for multivariate analysis. Positive or negative correlation
coefficients (𝛽) were attributed to each variable included
in the model. Calibration and discrimination of models
were performed. Model 2 showed the best performance
for mortality prediction. Therefore, it was chosen to be
the maternal severity index (MSI) [18]. Briefly, the SMI is
estimated through an equation which takes into account the
MSS (number of life-threatening conditions) and the pres-
ence of some associated specific conditions (life-threatening
condition identified in the first 24 hours of hospital stay,
severe preeclampsia, cancer, any marker of cardiovascular
failure, any marker of respiratory failure, and hysterectomy),
which are the variables significantly correlated withmortality
mentioned above. With the SMI thus estimated for each case
and the mean SMI for any specified group, the number of
expected deaths can be determined. When the number of
observed deaths is compared with the number of expected
deaths, the concept of standardized mortality ratio (SMR) is
used. To simplify the estimation of SMR, a calculator was
developed (Figure 1).
2.4. Analysis of Performance of Network Centers. The mean
MSI for each center was obtained and the standardized mor-
tality ratio (SMR)was calculated for each one (Figure 1). SMR
is the ratio between observedmortality in the population and
expected mortality by mortality prediction based on severity
of the case expressed by MSI. To allow calculation of SMR
for all centers, a value of 0.1 was attributed, when no death
was observed or there was no expected death due to the small
sample size and/or low complexity of cases in that center.
In the original model, the categorization of performance
was based on cutoff points selected assuming the normal
distribution into five classes of care and the understanding
that SMR < 0.5; that is, the occurrence of half or less than
the expected number of deaths could correspond to excellent
care.Thus, the five categories of performance were defined as
very high, high, intermediate, very low, and low [18].
In this analysis, SMR was calculated from the mean MSI
for each of the 27 study centers. Due to the relatively small
number of centers and to make analyses more consistent as
an exercise to evaluate large systems, the original classifica-
tion was modified, and groups were relocated to two new
categories. Categories “very high,” “high,” and “intermediate,”
including SMR < 0.5 to 1.24, were reclassified as “adequate”
care. Categories “low” and “very low,” with SMR of 1.25 to
>2, were recoded as “nonadequate.” Thus, this performance
was analyzed as a dependent variable. Using both groups
of adequacy of care, variables related to structure, process,
management, and delays were correlated as independent
variables. Although SMR was calculated for each health
facility, it should not be understood as an evaluation only
of the care the hospital provided but the general care those
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Table 2: Analyses of MSI, SMR, and level of performance for each center of the Brazilian Network for Surveillance of Severe Maternal
Morbidity.
Center MSI (%) Observed number of deaths Sample size Expected deaths SMR (95% CI) Performance
1 0.44% 5 566 2 2.01 (0.65–4.69) Non A
2 3.54% 4 96 3 1.18 (0.32–3.01) A
3 0.57% 0 253 1 0.00 (0.00–2.56) A
4 7.74% 6 112 9 0.69 (0.25–1.51) A
5 1.92% 2 210 4 0.50 (0.06–1.79) A
6 1.93% 17 1086 21 0.81 (0.47–1.30) A
7 1.81% 3 172 3 0.96 (0.20–2.82) A
8 0.25% 1 1050 3 0.38 (0.01–2.12) A
9 1.40% 4 155 2 1.84 (0.50–4.72) Non A
10 3.84% 30 609 23 1.28 (0.87–1.83) Non A
11 0.68% 3 186 1 2.37 (0.49–6.93) Non A
12 7.91% 8 98 8 1.03 (0.45–2.03) A
13 4.55% 3 154 7 0.43 (0.09–1.25) A
14 0.59% 0 841 5 0.00 (0.00–0.74) A
15 3.24% 9 369 12 0.75 (0.34–1.43) A
16 1.04% 11 945 10 1.12 (0.56–2.00) A
17 1.15% 5 294 3 1.48 (0.48–3.45) Non A
18 1.39% 1 66 1 1.09 (0.03–6.08) A
19 0.69% 8 920 6 1.26 (0.54–2.48) Non A
20 4.05% 8 118 5 1.67 (0.72–3.30) Non A
21 0.53% 0 48 0 0.00 (0.0–14.52) A
22 3.25% 5 74 2 2.08 (0.68–4.85) Non A
23 0.47% 3 465 2 1.37 (0.28–4.01) Non A
24 0.49% 1 263 1 0.78 (0.02–4.32) A
25 1.66% 3 65 1 2.78 (0.57–8.12) Non A
26 0.05% 0 59 0 0.00 (0.0–122.9) A
27 0.11% 0 281 0 0.00 (0.0–11.93) A
Overall 1.44% 140 9555 138 1.02 (0.86–1.20) A
A: adequate; Non A: nonadequate; MSI: maternal severity index; SMR: standardized mortality ratio.
women received. This includes not only the hospital activi-
ties/responsibilities but also those from the woman herself,
her family, community, and access to health services.
Furthermore, patient outcomes, their respective indi-
cators, and main causes of complication were evaluated
for both groups of level of performance. Finally, Poisson
multiple regression analysis was performed, using the level
of performance as a dependent variable, estimating the
prevalence ratio and its respective 95%CI to identify variables
independently associated with performance. A 5% statistical
significance level was used. All measures of effect in the study
design and their respective 𝑃 values were calculated after
adjusting for cluster effect.
3. Results
In this period, when these facilities took care of 82,388
deliveries with 82,144 live births (representing a fraction
of around 2.8% of all annual live births in the country),
9555 women had severe pregnancy complications, with 770
near miss cases and 140 maternal deaths. In Table 2, the
mean MSI, number of observed deaths, sample size (poten-
tially life-threatening and near miss conditions), expected
number of deaths, SMR, and, finally, the recategorized level
of performance of care are presented for each of the 27
centers, 17 being classified as having “adequate” and 10 as
“nonadequate” performance. Generally, the overall perfor-
mance of Network was adequate, since there were only two
more maternal deaths than expected due to severity of cases
(SMR = 1.02).
Table 3 shows the distribution of outcomes of severity
and of main causes of morbidity, according to the level of
performance of the centers. Although differences were not
significant, there was proportionally almost twice the propor-
tion of deaths among centers classified as “nonadequate” care.
Maternal health indicators also show that the occurrence of
maternal nearmiss was similar between performance groups,
but there was an almost twofold increase in the maternal
mortality ratio (MMR) in the group with nonadequate
care.
Structure indicators according to level of performance
are shown in Table 4. Centers with “adequate” performance
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Table 3: Distribution of cases of severe maternal morbidity according to the group of severity, main causes of morbidity, and level of
performance of care.
Level of performance of care
𝑃
1Adequate Nonadequate
𝑛 (%) 𝑛 (%)
Outcome of severity& 0.4
PLTC 5,543 (90.8) 3,102 (89.9)
MNM 494 (8.1) 276 (8.0)
MD 66 (1.1) 74 (2.1)
Total 6,103 (100.0) 3,452 (100.0)
Main causes
Hemorrhage 1,438 (23.6) 840 (24.3) 0.92
Hypertension 4,323 (70.8) 2,383 (69.0) 0.83
Infection 83 (1.4) 17 (0.5) 0.04
Clinical-surgical 614 (10.1) 409 (11.8) 0.5
Total 6,103 3,452
Maternal health indicators
MNMR 10/1000 LB 8.4/1000 LB 0.89
MMR 134/100.000 LB 225/100.000 LB <0.001
SMOR 11.4/1000 LB 10.6/1000 LB 0.13
LB 49.275 32.869
LB: live births; MD: maternal death; MMR: maternal mortality ratio; MNM: maternal near miss; PLTC: potentially life-threatening condition; SMOR: severe
maternal outcome ratio.
&Comparisons: PLTC × (NM +MD): 𝑃 = 0.721; (PLTC + NM) ×MD: 𝑃 = 0.123.
1
𝑃 value adjusted for cluster effect.
were located with an almost 2.5 higher prevalence in the
southeast and south of the country, but this difference was
not significant. When process and management indicators
(Table 5) were analyzed, there was twofold increase in ICU
admissions in adequate care centers, but this difference was
also not significant.
Association between delay in care and the level of per-
formance is shown in Table 6. Generally, both detection of
any type of delay and some specific categories of delays,
particularly those concerning the third delay (related to
quality of care), were significantly more common in the
nonadequate performance group. Considering all the pre-
dictive variables included in the multiple regression analysis
(Table 7), the use of magnesium sulfate and location of the
health center in the south or southeast were the main vari-
ables independently associatedwith adequate performance of
care.
4. Discussion
With the use of the MSI and SMR, it was possible to assess
the performance of centers from the Brazilian Network for
Surveillance of Severe Maternal Morbidity. This was a first
initiative to use the near miss concept as a tool for assessment
of case-mix and adequacy of care received in Obstetrics.
However, as already stated, this assessment of the quality of
obstetrical care is probably more appropriate for a specific
population that “receives” the care than for a specific health
facility that “provides” the care. This is because the global
assessment does not imply only the activities performed at
the hospital but also the characteristics of women and their
community services and access to health services. If a woman
arrives late at the hospital in a very severe almost dying
condition, she is more likely to die even if the hospital is
tertiary, well equipped, and with a good trained staff. The
responsibility for such a death cannot be attributed solely to
this hospital. In other words, the care provided by the hospital
can be adequate while the care received by the woman can be
not adequate.
In the classification of performance, sample size per
center corresponds to the number of cases with potentially
life-threatening conditions and threatening life conditions
(near miss and maternal death) and not the total number
of live births, because only women presenting with some
severity indicators were included in the study. Although cal-
culation of SMR for all centers was possible after attributing
a value of 0.1 to those that did not present any observed or
expected death, these estimates had low accuracy. Therefore,
the MSI seems limited and less precise for use in populations
with a small number of cases, with lower clinical severity
(low MSI) and those with no observed death. The lower
accuracy of estimates in these cases should increase attention
and care for interpreting the performance of these health
services.
Centers participating in this Brazilian Network were
selected considering their availability to participate in the
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Table 4: Distribution of study centers according to structure
indicators and level of performance of care.
Structure indicator@
Level of performance
𝑃
1
Adequate Nonadequate
Type of ICU ∗
Obstetric 5 (29) 2 (20) 0.68#
Only general ICU 9 (53) 5 (50) >1#
None 3 (18) 3 (30) 0.64#
Level of complexity >1#
Secondary 3 (18) 2 (20)
Tertiary 14 (82) 8 (80)
Geographic region 0.06#
North, Northeast,
and Center-West
5 (29) 7 (70)
Southeast and South 12 (71) 3 (30)
Level of government ∗
Municipal 2 (12) 2 (20) 0.61#
State 5 (29) 4 (40) 0.68#
Federal 7 (41) 3 (30) 0.69#
Nonpublic 3 (18) 1 (10) >1#
Total 17 (100) 10 (100)
@The following indicators were not taken into account: teaching hospital;
blood bank; neonatal ICU and round the clock anesthetic available, due to
the fact that almost all centers had these indicators.
∗Chi-square test not applicable for general comparison.
#Fisher Exact Test.
1
𝑃 value adjusted for cluster effect.
study, the total number of annual deliveries, and geo-
graphic location. Thus, the estimated sample size could be
achieved, ensuring a broad distribution in national territory.
Nevertheless, most of these hospitals were linked to large
university institutions or had teaching activities, and this
implies that they are mostly referral for healthcare of severe
pregnancy complications, with evidence-based protocols and
similar standards of care. The relative homogeneity of these
facilities may have contributed to the lack of significant
differences between levels of performance of care and most
variables related to the profile of severity of illness, cause
of morbidity, and structure and management indicators, in
addition to the limited number of centers participating in the
study.
Thegreater proportion of infectious causes among centers
with adequate performance may be perceived as better
adequacy to international protocols for the management of
sepsis [20], already widely known among academic medical
services. Referral of these cases to hospitals equipped with
a high complexity arsenal is a determining factor for the
survival of these patients.
As observed, there was an almost twofold increase in
proportion of deaths in centers with nonadequate perfor-
mance. However, the prevalence of maternal near miss was
practically the same in both groups of performance. This is
in agreement with recent knowledge that severe pregnancy
complications occur practically in the same frequency in all
countries and regions, regardless of the level of development
and availability of resources. In fact, the varying factor
is mortality, which is always higher in contexts of lower
development and scarce resources, as currently demonstrated
[21, 22].
In this study, information on potential delays in obtain-
ing care among women suffering severe complications was
collected. In addition to objective information from medical
charts, local researchers made a subjective assessment and
searched for the three types of delay in obtaining care
[19]. The presence of any delay in care was significantly
related to a worse performance of service. These results
are in agreement with the concept that the main preven-
tive factors in decreasing maternal mortality are delays
in the care process, from symptom identification by the
patient to the provision of adequate treatment by healthcare
professionals [19]. Globally there was a greater delay in
providing services in nonadequate care centers, mainly due
to the absence of blood products and difficulty in estab-
lishing communication between services and/or regulatory
centers.
These findings seem to follow a presumptive logic. Sub-
jects living in geographic regions with difficult access have
the greatest difficulty in seeking medical care, including
antenatal followup. Healthcare facilities close to these homes
are also probably on the outskirts of large cities and high-
complexity hospitals are usually in the center of these cities.
In general, this peripheral healthcare equipment does not
have an adequate structure to provide immediate care and
monitor complications. There is also difficulty in regulating
complex cases to large referral centers. Finally, successive
delays in providing care are related to a higher number of
severe outcomes and deaths.
This hypothesis may corroborate information that health
system strengthening may actually have the greatest impact
on improvement of clinical care [10]. For instance, prompt
action of the whole health system for hierarchization of care,
according to demand of severity, could ensure a reduction
in deaths by improving adequacy of care. These strategies
would go beyond the sole responsibility of the healthcare
managers. Most probably, social development actions, civil,
and transport infrastructure are necessary to correct deter-
mining factors for the health of these more vulnerable
populations.
TheMSI formortality prediction follows the same indica-
tions and limitations of similar models, such as the APACHE
and MPM. Use for individual evaluation is limited, since the
greatest outcome predictor is individual response to therapy
administered [2]. In addition, waiting to provide specific
measures only when certain markers of severity emerge is
not recommended. Individual clinical care is dynamic and
the use of severity scores for decision making may delay
healthcare, with poor provision of adequate resources. Most
existing scores consider the clinical parameters obtained in
the first 24 hours after ICU admission and do not assess time,
care, or alterations present before it [2]. MSI was developed
8 BioMed Research International
Table 5: Distribution of cases of severe maternal morbidity according to process and management indicators and level of performance of
care.
Process indicators
Level of performance
𝑃
1Adequate Nonadequate
𝑛 (%) 𝑛 (%)
Spontaneous access to facility 3.227 (54.2) 1.082 (35.7) 0.06
Total (a) 5.958 (100.0) 3.033 (100.0)
Way pregnancy is terminated (cesarean) 3.748 (61.7) 2.406 (69.9) 0.21
Total (b) 6.074 (100.0) 3.441 (100.0)
Admission to ICU 1.652 (27.1) 463 (13.4) 0.24
Long hospital stay (>7 days) 1.751 (28.7) 1.117 (32.4) 0.64
Referred to another place 46 (0.8) 32 (0.9) 0.68
Total 6.103 (100.0) 3.452 (100.0)
Any near miss criteria on admission 196 (35.0) 95 (27.1) 0.28
Total 560 (100.0) 350 (100.0)
Management indicators
Use of magnesium sulphate 2.932 (48.0) 1.685 (48.8) 0.96
Blood product transfusion 855 (14.0) 711 (20.6) 0.13
Central venous access 261 (4.3) 102 (3.0) 0.45
Intubation unrelated to anesthesia 190 (3.1) 106 (3.1) 0.97
Hysterectomy due to infection or hemorrhage 116 (1.9) 55 (1.6) 0.69
Total 6.103 (100.0) 3.452 (100.0)
Missing information for: (a) 564 cases; (b) 40 cases.
1
𝑃 value adjusted for cluster effect.
using data from the prehospital phase until discharge, using
several sources distributed all over the country, which may
increase the accuracy of its prediction capacity. However,
if the development of the model and the use in the same
population could be a limitation of the method, tests in other
samples are needed for external validation and in fact it was
already performed in a huge sample from the WHO study
[22].
The SMR may be perceived as the evaluation of perfor-
mance of a system rather than of a health service alone.
In this study, SMR was recategorized as “adequate” and
“nonadequate,” the cutoff point being the limit between
intermediate and low care from the original classification [18].
Thus a group of centers that actually had SMR above 1 was
classified as providing “adequate” care. Centers that could not
prevent any expected death and in some cases had a slight
increase in the number of deaths in relation to the expected
due to severity of their cases were categorized as having
adequate performance. Although this methodological option
may have reduced the identification of variables related to
actual excellent care (SMR between 0 and 0.8), it was a
strategy adopted as a form of simplifying data analysis and
prioritizing identification of centers with nonadequate per-
formance. In the future, with a larger number of participating
hospitals and subjects, it is likely that analysis with three
categories (e.g., high, intermediate, and low performance)
may be a valuable strategy for evaluating all the components
of performance individually.
5. Conclusions
In the Brazilian Network for Surveillance of Severe Maternal
Morbidity, the near miss approach was used to simulate anal-
ysis of an obstetric health system. After applying theMSI and
SMR, analysis of the performance of services received was
possible and its associated factors were assessed. Problems
arising from the health system organization were identified
as significant, especially those related to accessibility to health
services and quality of medical care provided.
The use of this specific tool for mortality prediction
may contribute to the analysis of obstetric health systems
and identification of weaknesses. Furthermore, it may help
to strengthen these systems, with an effective reduction in
deaths. Nevertheless, new studies in different populations
should be conducted for external calibration of tools devel-
oped in the Brazilian Network.
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Table 6: Distribution of cases of severe maternal morbidity according to occurrence of delays in obtaining obstetric care and level of
performance of care.
Type of delay, related to:
Level of performance
𝑃
1Adequate Nonadequate
𝑛 (%) 𝑛 (%)
(1) User factors 567 (10.0) 286 (10.5) 0.89
Delay in seeking health services 303 (5.4) 139 (5.1) 0.92
Refusal of treatment 276 (4.9) 150 (5.5) 0.66
Unsafe abortion 48 (0.9) 3 (0.1) <0.001
Total 5.645 2.735
(2) Health service accessibility 1.945 (34.4) 961 (35.0) 0.93
Total 5.647 2.744
Difficulty accessing antenatal care 68 (1.1) 58 (2.1) 0.42
Difficulties with transportation city/hospital 54 (0.9) 63 (2.2) 0.06
Total 6.029 2.819
Absent/inadequate antenatal care 1.909 (33.8) 783 (28.6) 0.19
Geographic difficulty in accessing health service 22 (0.4) 176 (6.4) <0.001
Total 5.645 2.735
(3) Quality of medical care 1.046 (17.3) 1.263 (42.6) 0.01
Total 6.039 2.962
Absence of blood products 20 (0.3) 37 (1.3) 0.01
Lack of medication 67 (1.1) 50 (1.8) 0.38
Difficulty in communication between hospital and regulatory center 250 (4.1) 529 (18.8) 0.004
Lack of trained staff 127 (2.1) 144 (5.1) 0.09
Difficulty in monitoring 180 (3.0) 229 (8.1) 0.18
Total 6.029 2.819
Delay in referral/transfer of the case 143 (2.4) 149 (5.2) 0.07
Delay in diagnosis 327 (5.4) 160 (5.6) 0.96
Delay in starting treatment 416 (6.9) 186 (6.5) 0.93
Improper management of the case 589 (9.7) 629 (21.8) 0.13
Total 6.052 2.879
Any delay 2.750 (48.3) 1.937 (64.2) 0.04
Total 5.698 3.018
1
𝑃 value adjusted for cluster effect.
Table 7: Variables independently associated with adequate perfor-
mance (Poisson multiple analysis1 𝑛 = 9555).
Variable PR 95% CI PR 𝑃1
Use of magnesium sulfate 1.44 1.04–1.98 0.03
Geographic region (SE, S) 2.21 1.05–4.65 0.04
1
𝑃 value adjusted for cluster effect; PR: prevalence ratio; SE: Southeast; S:
South.
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